-
Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) fell $2.11 (14%) to $12.81 on Friday after reporting 1Q13 financial results late Thursday that missed the Street. The company reported a 1Q13 loss per share of $0.65, wider …
Published on 5/10/2013
-
Sequenom Inc. (NASDAQ:SGNM) gained $0.47 (13%) to $4.04 on Friday after the company reported 1Q13 revenues of $38.5 million, up 158% over $14.9 million in 1Q12. The Street was expecting $38.3 million. Diagnostics …
Published on 5/10/2013
-
Warburg Pincus raised $11.2 billion for its eleventh fund, Warburg Pincus Private Equity XI. Warburg invests in healthcare, energy, financial services, technology, media and telecommunications and consumer, industrial …
Published on 5/10/2013
-
Japanese gene therapy company AnGes MG Inc. (Tokyo:4563) said it hopes to raise at least Y5.1 billion ($51.2 million) through May 19, 2014, through the exercise of 20,000 stock acquisition rights by Merrill Lynch Japan …
Published on 5/9/2013
-
Shares of Dendreon Corp. (NASDAQ:DNDN) slid $0.71 (15%) to $4.03 on Thursday after the company reported 1Q13 net revenues of prostate cancer drug Provenge sipuleucel-T -- the company's sole marketed product -- that …
Published on 5/9/2013
-
Frazier Healthcare raised $281.8 million of a planned $300 million for its seventh fund, Frazier Healthcare VII, according to an SEC filing. Frazier's prior fund closed at $600 million in 2007. The firm is primarily …
Published on 5/9/2013
-
Antisense technology company Isis Pharmaceuticals Inc. (NASDAQ:ISIS) raised $171 million through the sale of 9 million shares at $19 million in a follow-on underwritten by Goldman Sachs; JPMorgan; Stifel Nicolaus Weisel…
Published on 5/9/2013
-
NPS Pharmaceuticals Inc. (NASDAQ:NPSP) reported 1Q13 earnings on Thursday, including $654,000 in the first sales of Gattex teduglutide, which the company launched in the U.S. in February to treat short bowel syndrome (…
Published on 5/9/2013
-
Omeros Corp. (NASDAQ:OMER) proposed late Thursday to raise $16.2 million through the sale of 3.9 million shares at $4.14 in a registered direct offering to RA Capital Management and undisclosed investors. The price is a…
Published on 5/9/2013
-
Receptos Inc. (NASDAQ:RCPT) raised $72.8 million through the sale of 5.2 million shares at $14 in an IPO late Wednesday. Credit Suisse; Leerink; BMO Capital Markets; and Wedbush are underwriters. The price -- at the low…
Published on 5/9/2013
-
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) disclosed in a 10-Q late Tuesday that a modified REMS for narcolepsy drug Xyrem sodium oxybate could include new requirements that could "make it easier for future generic …
Published on 5/8/2013
-
Lumena Pharmaceuticals Inc. (San Diego, Calif.) debuted on Wednesday with $23 million in a series A round led by Alta Partners, with participation from Pappas Ventures and RiverVest Venture Partners. Pappas' David …
Published on 5/8/2013
-
PeptiDream Inc. (Tokyo, Japan) said it plans to sell 1.7 million shares at Y1,720-Y1,920 in an IPO on the Tokyo Stock Exchange's market of the high-growth and emerging stocks (Mothers). At the Y1,820 mid-point, …
Published on 5/8/2013
-
Quintiles Transnational Corp. (NYSE:Q) raised $525 million through the sale of 13.1 million shares at $40 in an IPO on Wednesday. The price -- at the high-end of Quintiles' proposed $36-$40 range -- values the CRO at $5…
Published on 5/8/2013
-
Vivus Inc. (NASDAQ:VVUS) was up $1.17 (10%) to $13.21 on Wednesday after CEO Leland Wilson disclosed on a conference call to discuss the company's 1Q13 earnings that Vivus began discussions with large pharmas to "…
Published on 5/8/2013
-
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) reported $6.4 million in net sales of leukemia drug Iclusig ponatinib -- Ariad's sole marketed product -- in its first full quarter of availability. The Street was expecting $5 …
Published on 5/7/2013
-
Erytech Pharma S.A. (Euronext:ERYP) closed off EUR 0.12 to EUR 11.48 in its first day of trading on NYSE Euronext Paris on Tuesday. Last Friday, the company raised EUR 16.7 million ($21.8 million) through the sale of 1.…
Published on 5/7/2013
-
Portola Pharmaceuticals Inc. (South San Francisco, Calif.) amended its IPO and now plans to sell 6.9 million shares at $13-$16. At the $14.50 mid-point, Portola would raise $100.1 million and be valued at $469.2 million…
Published on 5/7/2013
-
Cancer company Heat Biologics Inc. (Miami Beach, Fla.) filed to raise up to $20 million in an IPO underwritten by Aegis Capital. This year, Heat Biologics plans to start Phase II testing of its lead candidate, HS-110, …
Published on 5/6/2013
-
Santarus Inc. (NASDAQ:SNTS) jumped $2.13 (11%) to $21 in early after-hours trading after announcing 1Q13 earnings late Monday that beat the Street. Total revenues for the quarter were $79.4 million, including $41.5 …
Published on 5/6/2013
-
Stat-Diagnostica and Innovation (Barcelona, Spain) raised $22.1 million in a series B round led by new investor Kurma Life Sciences Partners. New investors Idinvest Partners; Boehringer Ingelheim Venture Fund; and Caixa…
Published on 5/6/2013
-
Alcobra Ltd. (Tel Aviv, Israel) amended its IPO and now plans to sell 2.3 million shares at $10-$12. An $11 price would raise $25 million and value the company at $112.8 million. Last month, the company said it planned …
Published on 5/3/2013
-
Erytech Pharma S.A. (Lyon, France) raised EUR 16.7 million ($21.8 million) through the sale of 1.4 million shares at EUR 11.60 in an IPO on NYSE Euronext Paris. The EUR 11.60 price values the company at EUR 64.3 million…
Published on 5/3/2013
-
Gilead Sciences Inc. (NASDAQ:GILD) gained $2.97 to $55.15 and hit its all-time split-adjusted high closing price on Friday after making two announcements Thursday. Thursday morning, the company reported interim data for…
Published on 5/3/2013
-
AltheRx Pharmaceuticals (Exton, Pa.) raised $15 million in a series A round led by existing investor Becker Ventures. Becker's Jim Bennethum also took over as CEO and became a director, replacing Shawn O'Brien, who …
Published on 5/2/2013